How GLP-1 medications work

GLP-1 stands for glucagon-like peptide-1, a hormone the gut releases after eating that signals fullness and helps regulate blood sugar. GLP-1 medications are lab-made versions of that signal. The class was first developed to treat type 2 diabetes and is now also used, under medical supervision, to support weight management.

"GLP-1 medications" is a drug class, not a single product. Different medications in the class share the same basic mechanism but differ in how they are made, how they are taken, and how often. Much of what is known about the class comes from products the FDA has approved; compounded versions are not FDA-approved and are not individually tested for safety or effectiveness. For independent background, see NIH / NIDDK — Weight Management.

Three effects do most of the work:

• More fullness. They increase the sense of satiety, so meals feel satisfying with less food.
• Slower digestion. They slow gastric emptying, so the stomach stays full longer.
• Less hunger. They act on appetite signaling in the brain, which can reduce hunger and preoccupation with food.

For many people the result is that eating less feels more natural rather than forced. Responses vary from person to person, and medication works best alongside changes to nutrition and activity. GLP-1 treatment is not a guaranteed outcome and is not right for everyone.

Providers usually start at a low dose and increase it gradually over several weeks. This is called titration, and it helps the body adjust while limiting side effects. Reaching a maintenance dose can take time, and your provider will tell you how and when to adjust. Because everyone responds differently, the timeline and the experience are individual.

The most common side effects are digestive: nausea, and sometimes vomiting, diarrhea, constipation, or reflux. They are usually mild to moderate and often ease as the body adjusts, especially with slow titration, smaller meals, and staying hydrated.

Serious side effects are less common but possible. GLP-1 medications carry important safety warnings, including a boxed warning based on a risk of thyroid C-cell tumors seen in animal studies. They should not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider about your full medical history. This is not a complete list of side effects or warnings.

Eligibility is a medical decision made by a licensed provider, not by a questionnaire alone. Providers generally weigh factors such as body mass index (BMI), weight-related health conditions, your medical history, and other medications you take. GLP-1 treatment is not appropriate for everyone, including during pregnancy or with certain medical histories. The only way to know is a provider evaluation.

GLP-1 treatment on Panterra is priced per refill, all-in, with no membership required to be a patient. The price includes the medication, the provider, follow-ups, and shipping. The provider consultation fee is part of that price, and it is itemized before you pay. Each treatment page lists its current "starting at" price.

See current pricing on the treatment pages: Weekly weight care and Dual-action weight care (also available under Hygeia).

1. You complete a health intake online.
2. A licensed U.S. provider reviews your information.
3. If a GLP-1 treatment is appropriate for you, the provider issues a prescription.
4. Your medication ships to you, and follow-ups are included in the price.

If a treatment is not appropriate, the provider will tell you and may suggest other options. A prescription is never guaranteed.

In the Panterra community, a free, moderated space for anyone on or considering a GLP-1, whatever their provider. You can pick a name, post anonymously if you want, and compare notes on food, movement, side effects and getting started. Members share their own experience, not medical advice, so questions about your treatment belong with your provider.

Prescription required. GLP-1 medications are available only with a prescription from a licensed provider after an evaluation.

Compounded medications are not FDA-approved. Some GLP-1 treatments offered through Panterra are compounded. The FDA does not review compounded medications for safety, effectiveness, or quality, and they are not tested in clinical trials the way FDA-approved medications are. See our guide to compounded medications.

Not for everyone. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. Tell your provider about all your conditions and medications. This page does not list every risk.

This is education, not medical advice. It does not replace a conversation with your provider, and it is not a diagnosis or a recommendation to use any specific treatment. For a medical emergency, call 911.

Authoritative background: NIH / NIDDK — Weight Management and FDA — Compounding and FDA: Questions and Answers.